Stericycle Inc (NASDAQ:SRCL) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA cut its position in shares of Stericycle Inc (NASDAQ:SRCL) by 30.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 700 shares of the business services provider’s stock after selling 300 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Stericycle were worth $36,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Bank of New York Mellon Corp boosted its position in shares of Stericycle by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 923,897 shares of the business services provider’s stock worth $44,116,000 after buying an additional 43,112 shares during the period. Earnest Partners LLC boosted its position in shares of Stericycle by 20.6% in the second quarter. Earnest Partners LLC now owns 414,326 shares of the business services provider’s stock worth $19,784,000 after buying an additional 70,892 shares during the period. Callodine Capital Management LP boosted its position in shares of Stericycle by 52.3% in the second quarter. Callodine Capital Management LP now owns 220,872 shares of the business services provider’s stock worth $10,547,000 after buying an additional 75,872 shares during the period. Northern Trust Corp boosted its position in shares of Stericycle by 3.7% in the second quarter. Northern Trust Corp now owns 880,250 shares of the business services provider’s stock worth $42,031,000 after buying an additional 31,193 shares during the period. Finally, UBS Asset Management Americas Inc. boosted its position in shares of Stericycle by 8.4% in the second quarter. UBS Asset Management Americas Inc. now owns 3,608,752 shares of the business services provider’s stock worth $172,318,000 after buying an additional 278,461 shares during the period.

NASDAQ:SRCL traded down $0.18 during trading hours on Wednesday, reaching $61.42. 14,013 shares of the stock were exchanged, compared to its average volume of 1,011,940. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 1.19. The firm has a 50 day simple moving average of $53.52 and a 200-day simple moving average of $48.87. Stericycle Inc has a 52 week low of $34.36 and a 52 week high of $63.02. The stock has a market capitalization of $5.69 billion, a P/E ratio of 13.80, a P/E/G ratio of 2.98 and a beta of 1.25.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, October 31st. The business services provider reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.68 by $0.12. Stericycle had a positive return on equity of 10.52% and a negative net margin of 13.26%. The company had revenue of $833.10 million for the quarter, compared to the consensus estimate of $842.21 million. During the same quarter last year, the business posted $1.03 EPS. Stericycle’s quarterly revenue was down 2.6% compared to the same quarter last year. As a group, analysts expect that Stericycle Inc will post 2.62 earnings per share for the current year.

SRCL has been the subject of a number of analyst reports. Bank of America reissued an “underperform” rating and issued a $44.00 price target (down previously from $46.00) on shares of Stericycle in a report on Wednesday, July 17th. Robert W. Baird raised Stericycle from an “underperform” rating to a “neutral” rating and set a $44.00 price target for the company in a report on Friday, August 2nd. TheStreet raised Stericycle from a “d+” rating to a “c-” rating in a report on Thursday, October 31st. ValuEngine raised Stericycle from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 6th. Finally, BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a report on Saturday, October 19th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $51.80.

In other news, EVP Daniel Ginnetti sold 6,000 shares of the stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $55.47, for a total transaction of $332,820.00. Following the sale, the executive vice president now directly owns 15,943 shares in the company, valued at approximately $884,358.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.30% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Featured Story: Equal Weight Rating

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.